The FDA announced on March 3, 2025, that Terumo Cardiovascular Systems Corporation is recalling its CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe due to a hazard involving unavailable data displays. The agency issued recall number Z-1492-2025 for the voluntary Class II action.
How to tell if you have it
- Brand: Terumo
- Product: CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe
- Catalog Number: REF CD1754
- UDI/DI: 00886799001882
- Serial Numbers: H0050095-H0050110, H0050112-H0050116, H0050118-H0050124, H0050126, H0050131-H0050134, H0050136, H0050140-H0050142
- Units affected: 37
- Sold in: IL, TX, NY, MI, FL, NV, and Australia, New Zealand
The hazard
According to the FDA, during some clinical cases, the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these instances, a yellow low-limit alarm is triggered to the user due to the dashed-out value.
Context
GovInfoNow's records show Terumo Cardiovascular Systems Corporation has 20 other recalls on record since June 27, 2017. Other recent recalls of similar products include a May 28, 2025 recall for temperature inaccuracy risk and a February 20, 2024 recall for high crack check valve risk of myocardial damage. A September 14, 2026 recall was issued for the NOxBOXi Nitric Oxide Delivery System regarding potential for irregular oxygen readings.